Headline News about DICE Therapeutics, Inc. - Common Stock
Recap: DICE Therapeutics Q1 Earnings
May 11, 2023
Via Benzinga
Via Benzinga
Where DICE Therapeutics Stands With Analysts
November 15, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|